The companies that are expected to see active trade on Tuesday are: Archer-Daniels-Midland, CME Group, Pfizer, Baker Hughes, Emerson Electric, General Cable, Discovery Communications, Fiserv, Rogers Corp, Fidelity National Information Services, Jds Uniphase Corp. and Tenet Healthcare Corp.
Little spheres deliver medicine slowly and keep it inside the knee.
The conglomerate will divide itself into a medical products firm (which will retain the “Abbott” name) and an as-yet-unnamed pharmaceutical research & development entity.
Biocon Ltd, India top biotechnology company, reported a 4 percent drop in quarterly profit due to higher energy costs and rise in wages, but said strong demand from branded formulations offered opportunities for growth.
The Chicago-based company will keep its diversified medical products division under the Abbott name and spin off its research-based pharmaceuticals unit.
Cytisine, a plant-based drug discovered by the Soviet Union more than 40 years ago, may be the key to lowering cigarette smoking rates in the developing world.
Combination of Afinitor® and Aromasin can buy you more time before the breast cancer situation worsens.
Scientists have found a way to prevent HIV from damaging the immune system and say their discovery may offer a new approach to developing a vaccine against AIDS.
Despite the FDA advisory panel's backing, RBC Capital Markets does not believe Johnson & Johnson's (NYSE: JNJ) Xarelto is well positioned to receive marketing approval on Nov. 5.
IBM, the No. 2 computer services company, has snapped up technology players in Canada and the UK -- demonstrating an appetite for new technologies but also for tax advantages.
New York City-based Pfizer Inc. gained FDA approval for their drug Xalkori, the first new medicine in several years for deadly, advanced lung cancer, according to new research.
Thousands of Washington lobbyists are scrambling to influence the work of a congressional super committee given the job of identifying up to $1.5 trillion in deficit reductions, with many worried about how to gain access to its 12 members.
An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market.
The Food and Drug Administration (FDA) has given the approval for a new Pfizer drug which will be useful for treating certain group of lung cancer patients having specific genetic mutation.
Xalkori is a Pfizer drug, and it works by targeting specific genes found certain patients. This gene is called the abnormal anaplastic lymphoma kinase (ALK) gene and is present in about 1 to 7 percent of non-small cell lung cancer patients.
Kodak's patent auction can benefit shareholders as well as the U.S.
Recent industry buzz on Pfizer's alleged strategy to sell its cholesterol reducer-blockbuster drug, Lipitor as an over-the-counter pill, reinforces debate on the safe compliance of prescription drugs when sold as OTC's.
The S&P 500 turned negative for the year on Tuesday as the wrangling over the U.S. debt ceiling faded and investors turned their attention to the stalling economy.
Wall Street fell for a sixth day on Monday on renewed angst about Washington's ability to reach a deal on raising the U.S. debt ceiling and following disappointing news from the manufacturing sector.
Stocks fell a sixth day on Monday as weaker-than-expected U.S. manufacturing data and uncertainty over the debt deal in Washington kept the mood skittish on Wall Street.
Pharmaceutical giant Pfizer (PFE) is considering selling its animal health and baby food units in hopes of appeasing shareholders' demands.
Researches have found that Chantix, the popular Pfizer drug that helps people quit smoking, may instead give people heart attacks and other cardiovascular problems.
